A bone graft that
modulates human
immune response.
That's how you
move the needle.
Reducing non-unions is a win-win for
surgeons and patients alike.
But how can you achieve it?
MagnetOs isn't like other bone grafts. It
grows bone even in soft tissue thanks to our
unique NeedleGrip™ surface technology
which provides traction for our body's vitally
important 'pro-healing' immune cells (M2
macrophages).
*†1
This in turn, unlocks previously untapped
potential to stimulate stem cells - and form
new bone throughout the graft.
2-4
The growing body of science behind
MagnetOs is called osteoimmunology.
But for patients and surgeons it means one
thing: more predictable fusions.
*
So, are you ready to move the needle?
Get in touch with us today at:
ndoutmore.kurosbio.com/beckers-spine-21
References: 1. Duan, et al. eCM. 2019;37:60-73. 2. Data on File. 3. Van Dijk, et al. JOR Spine. 2018;e1039. 4. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090.
*MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ovine model of posterolateral fusion. Results from in vivo laboratory testing may not be predictive of clinical
experience in humans. For important safety and intended use information please visit https://kurosbio.com/resources/instructions-for-use-ifu-magnetos-putty-us/.
†
MagnetOs is not cleared by FDA as an osteoinductive bone graft.
Manufactured by Kuros Biosciences BV, Prof Bronkhorstlaan 10, Building 48, 3723 MB Bilthoven, The Netherlands.
PROMO/MAG/US/012-21/R00
May
'21